IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells

Gut

Volumn 64, Issue 9, 2015, Pages 1466-1475

  Miot, Charline ^a,b,c   Beaumont, Elodie ^d,e   Duluc, Dorothée ^a,b,c   Le Guillou Guillemette, Hélène ^a,b   Preisser, Laurence ^a,b,c   Garo, Erwan ^a,b,c   Blanchard, Simon ^a,b,c   Fouchard, Isabelle Hubert ^b   Créminon, Christophe ^f   Lamourette, Patricia ^f   Fremaux, Isabelle ^a,b,c   Calès, Paul ^a,b   Lunel Fabiani, Françoise ^a,b   Boursier, Jérôme ^b   Braum, Oliver ^g   Fickenscher, Helmut ^g   Roingeard, Philippe ^d,e   Delneste, Yves ^a,b,c   Jeannin, Pascale ^a,b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c Team 12   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e INSERM   (France)

^f Institut National de la Recherche Agronomique   (France)

^g UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD16 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 26; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTIVIRUS AGENT; BIOLOGICAL MARKER; CYTOKINE; FC RECEPTOR; IL26 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INTERFERON PRODUCTION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION; BLOOD; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECTS; HEPATITIS C, CHRONIC; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; NEEDLE BIOPSY; NONPARAMETRIC TEST; SEVERITY OF ILLNESS INDEX;

ANTIGENS, CD56; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; INTERLEUKINS; KILLER CELLS, NATURAL; MALE; RECEPTORS, IGG; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84941278102     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306604     Document Type: Article

References (45)

1. Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29(Suppl 1):74-81.
2. Seeff LB. The history of the "natural history" of hepatitis C (1968-2009). Liver Int 2009;29(Suppl 1):89-99.
3. Neumann-Haefelin C, Thimme R. Adaptive immune responses in hepatitis C virus infection. Curr Top Microbiol Immunol 2013;369:243-62.
4. Horner SM, Gale M Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 2013;19:879-88.
5. Soriano V, Peters MG, Zeuzem S. New therapies for hepatitis C virus infection. Clin Infect Dis 2009;48:313-20.
6. Golden-Mason L, Rosen HR. Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunol Rev 2013;255:68-81.
7. Stegmann KA, Bjorkstrom NK, Veber H, et al. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010;138:1885-97.
8. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol 2013;31:163-94.
9. Yoon JC, Lim JB, Park JH, et al. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells. J Virol 2011;85:12557-69.
10. Cheent K, Khakoo SI. Natural killer cells and hepatitis C: action and reaction. Gut 2011;60:268-78.
11. Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009;51:458-67.
12. Kawarabayashi N, Seki S, Hatsuse K, et al. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000;32:962-9.
13. Varchetta S, Mele D, Mantovani S, et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 2012;56:841-9.
14. Fickenscher H, Hor S, Kupers H, et al. The interleukin-10 family of cytokines. Trends Immunol 2002;23:89-96.
15. Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29:71-109.
16. Sabat R. IL-10 family of cytokines. Cytokine Growth Factor Rev 2010;21:315-24.
17. Knappe A, Hor S, Wittmann S, et al. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 2000;74:3881-7.
18. Braum O, Pirzer H, Fickenscher H. Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells. Antiinflamm Antiallergy Agents Med Chem 2012;11:221-9.
19. Donnelly RP, Sheikh F, Dickensheets H, et al. Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev 2010;21:393-401.
20. Dambacher J, Beigel F, Zitzmann K, et al. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2009;58:1207-17.
21. Sheikh F, Baurin VV, Lewis-Antes A, et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 2004;172:2006-10.
22. Hor S, Pirzer H, Dumoutier L, et al. The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem 2004;279:33343-51.
23. Corvaisier M, Delneste Y, Jeanvoine H, et al. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol 2012;10:e1001395.
24. Donnelly RP, Dickensheets H, O'Brien TR. Interferon-lambda and therapy for chronic hepatitis C virus infection. Trends Immunol 2011;32:443-50.
25. Braum O, Klages M, Fickenscher H. The cationic Cytokine IL-26 differentially modulates virus infection in culture. PLoS One 2013;8:e70281.
26. Duluc D, Tan F, Scotet M, et al. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta. Eur J Immunol 2009;39:2877-84.
27. Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986;136:4480-6.
28. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76:13001-14.
29. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-6.
30. Ferraris P, Beaumont E, Uzbekov R, et al. Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Cell Mol Life Sci 2013;70:1297-306.
31. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809, table of contents.
32. Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013;19:859-68.
33. Ahlenstiel G, Titerence RH, Koh C, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010;138:325-35 e1-2.
34. Holder KA, Stapleton SN, Gallant ME, et al. Hepatitis C Virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions. J Immunol 2013;191:3308-18.
35. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423-30.
36. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-7.
37. Chang Q, Wang YK, Zhao Q, et al. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol 2012;27:273-8.
38. Saadoun D, Boyer O, Trebeden-Negre H, et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis. J Hepatol 2004;41:1031-7.
39. Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013;1832:1061-9.
40. Eisenhardt M, Glassner A, Kramer B, et al. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS One 2012;7:e38846.
41. Heim MH. Innate immunity and HCV. J Hepatol 2013;58:564-74.
42. Metz P, Dazert E, Ruggieri A, et al. Identification of type I and type II interferoninduced effectors controlling hepatitis C virus replication. Hepatology 2012;56:2082-93.
43. Hiroishi K, Ito T, Imawari M. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence. J Gastroenterol Hepatol 2008;23:1473-82.
44. Zhu H, Liu C. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 2003;77:5493-8.
45. Nagalakshmi ML, Murphy E, McClanahan T, et al. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 2004;4:577-92.